Published: Wed, November 15, 2017
Research | By Derrick Holloway

FDA approves first 'trackable' pill Abilify


13, 2017, the FDA approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them.

The pill, called Abilify MyCite, adds a tiny sensor, no larger than a grain of sand, made of silicon, copper, and magnesium inside a tablet of Abilify, a drug used to treat mental disorders like schizophrenia, bipolar disorder, and is used in conjunction with antidepressants to treat depression.

What are some potentially unsafe risks of Abilify MyCite?

Once a patient swallows the pill a sensor sends a message to a wearable patch.

US Navy sends 'powerful message' in rare carrier exercise
The Reagan - homeported in Japan - joined the other two carriers, which are based in the Western United States. The exercise involves three US aircraft carrier groups, making it the largest show of force in a decade.

Of the many hurdles drugmakers face - mastering complex science, navigating regulations, crafting successful marketing campaigns - patient adherence remains one of the most hard to clear. A report from the IMS Institute for Healthcare Informatics estimates that the cost of patients not taking their medication correctly is about $100 billion each year.

Technology has been a vital tool for manufacturers and healthcare providers looking to improve patient adherence.

In the long run, such digital pills can also be used to manage patients with other complicated treatment routines, such as diabetes or heart conditions.

"The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers", Dr. Mitchell Mathis, director of the division of Psychiatry Products in the FDA's Center for Drug Evaluation and Research, said in a statement.

Mask fools Apple iPhone X's Face ID
The company may have purposefully done a poor job setting up Face ID so it was easier to trick, which would discredit the results. Apple claims that the FaceID is foolproof and can't be hacked using a two-dimensional picture of the user to unlock the phone.

Abilify MyCite's future isn't certain, however.

Abilify MyCite hasn't been proven to improve patient compliance with taking medication on a prescribed schedule, the FDA stressed. Whether this new drug-device combo will actually prop up adherence is also quite unclear.

According to the news release, the FDA granted the approval of Abilify MyCite to Otsuka Pharmaceutical Co., Ltd.

Using Abilify MyCite to track drug use in real time or in the event of an emergency is not ideal, however, as there may be a delay or problem in the detection.

What to do with Jared Goff on Sunday
The third quarter did not end before another touchdown was scored by Woods to put the game out of reach for the Texans . A feisty Texans defense made the upstart Rams look entirely mundane for two-plus quarters Sunday.

Providing they sign a consent form, patients can allow up to four other people, including their doctors, caregivers, and family members, to access the data via a web-based portal.

Like this: